Expert Video - How are lung cancer treatments approved, based on clinical trial outcomes?
Manish Patel, DO, Associate Professor of Medicine at the University of Minnesota, discusses how lung cancer clinical trial data are analyzed and how the FDA approvestreatments for lung cancer. Dr. Patel also explains how the results of early lung cancer studies may lead to approval. He also explains the importance of reviewing lung cancer clinical trials to make sure the trial treatment is better than the standard of care for lung cancer and is safe.
Share with family and friends:
Click here to take our SURVEY Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.
This educational activity has been developed by
A Breath of Hope Lung Foundation and Mechanisms in Medicine Inc.
This activity is supported by educational grants from AstraZeneca Pharmaceuticals, Bristol-Myers Squibb Foundation Inc., Bristol-Myers Squibb Grants and Giving, Foundation Medicine, Genentech, Jazz Pharmaceuticals, Merck Sharp & Dohme LLC, Neogenomics, Novartis, Pfizer, and Takeda Oncology.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.